Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,835.00
-25.00 (-0.65%)
Aug 12, 2026, 1:04 PM KST

Oncocross Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
475.15370.461,07291.52150.25100
Revenue Growth
-55.77%-65.45%1071.49%-39.08%50.24%11.11%
Gross Profit
439.58339.241,0683.2128.5161.34
Operating Income
-8,957-8,828-6,965-6,810-9,999-7,339
Net Income
-9,309-8,929-6,483-4,214-10,204-13,146
Earnings Per Share
-773.91-746.72-619.00-473.00-1161.74-2451.00
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
27,24723,43320,75116,6427,00814,241
Total Debt
8,3985,360548.94115.89318.32,188
Net Cash (Debt)
18,84918,07320,20216,5266,69012,052
Net Cash Growth
13.66%-10.54%22.24%147.03%-44.49%387.40%
Net Cash Per Share
1567.091511.461928.881854.72761.642246.77

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-6,270-7,405-5,524-4,906-8,200-6,276
Capital Expenditures
-2,380-3,297-163.07-7.1-327.46-257.94
Free Cash Flow
-8,650-10,702-5,687-4,913-8,527-6,534
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
92.51%91.57%99.60%3.51%18.98%61.34%
Operating Margin
-1884.98%-2383.02%-649.58%-7440.64%-6655.30%-7339.31%
Pretax Margin
-1959.09%-2410.17%-604.66%-4486.41%-6791.63%-13146.17%
Profit Margin
-1959.09%-2410.17%-604.66%-4604.70%-6791.63%-13146.17%
FCF Margin
-1820.41%-2888.81%-530.40%-5368.32%-5675.38%-6534.38%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
105.98311.0570.12---